Screening Libraries
 |
 |
|
|
|
| Catalog No. | Size | Price | Stock | |
| S20001 | 1mg/well * 52 Compounds | Get quote | In stock | Contact Us |
| S20001 | 2mg/well * 52 Compounds | Get quote | In stock |
| manager@chemfaces.com | |
| Tel | (0086)-27-8423-7683 |
| Shelf Life | (0086)-27-84254680 |
| Manufacturer | Wuhan ChemFaces Biochemical Co., Ltd. |
| Container | 96 Well Format Sample |
| Storage | Protected from air and light, refrigerate or freeze(2-8 °) |
| Shelf Life | 24 months (2-8 °) |
| Intended Use | For research use only. Not for human use. Not sell to patients |
| 1. The products in the ChemFaces screening libraries are all from plants. |
| 2. The biological activities or pharmacological activities of all the ChemFaces products are derived from the databases of all over the world the latest literatures, patent reports and clinical validation, you can according to the product manuals on our website to access the relevant literatures, hope that our informations can give some inspirations and help to your research. |
| 3.The collections of unique natural products, which include antioxidants, anti-inflammatory, antibacterial, anticancer, and ect. Can be used for high throughput screening (HTS) and high content screening (HCS), is to help you carry out new drug screening, the emergence of new indications and other professional tools. |
| 4.Structurally diverse, medicinally active, and cell permeable, NMR and HPLC validated to ensure high purity. |
| 5. ChemFaces offers customized bioactive screening libraries , whereby you choose the specific compounds you want in the library, the quantities, plate map, concentration, and format (dry/solid or DMSO solution). |
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| a | Empty | 20(R)-Ginsenoside Rg3 | Ginsenoside Ro | Ginsenoside F1 | Ginsenoside F2 | Ginsenoside Compound K | (20S)-Protopanaxdiol | Pseudoginsenoside F11 | Ginsenoside Rb1 | Ginsenoside Rb2 | Ginsenoside Rb3 | Empty |
| b | Empty | Ginsenoside Rg1 | Ginsenoside Rg2 | Ginsenoside Rg3 | Ginsenoside Rh1 | 20(S)-Ginsenoside Rh2 | Dammarenediol II | Ginsenoside Rh3 | Ginsenoside Rc | Ginsenoside Rd | Ginsenoside Rf | Empty |
| c | Empty | Pseudoginsenoside RT5 | Ginsenoside F3 | (20R)-Protopanaxdiol | 20(R)-Protopanaxatriol | Panaxadiol | Panaxatriol | Notoginsenoside R2 | Ginsenoside Rk3 | Ginsenoside Rh4 | Ginsenoside Rg5 | Empty |
| d | Empty | Ginsenoside Rk1 | Ginsenoside Rs3 | Ginsenoside Rk2 | Notoginsenoside T5 | (20S)-Protopanaxatriol | Ginsenoside Re | 20(R)-Ginsenoside Rh2 | 25(S)-Hydroxyprotopanaxatriol | Ginsenoside Rg4 | 3-Acetoxy-24-hydroxydammara-20,25-diene | Empty |
| e | Empty | Ginsenoside Rg6 | Ginsenoside F4 | 20(S),24(R)-Ocotillol | Panaxydol | (20R)-Ginsenoside Rh1 | 20R-Ginsenoside Rg2 | 25(R)-Hydroxyprotopanaxadiol | Pseudoginsenoside RT1 | Ginsenoside F5 | 20-O-Glucoginsenoside Rf | Empty |
| f | Empty | Panaxyne | Empty | Empty | Empty | Empty | Empty | Empty | Empty | Empty | Empty | Empty |
| g | Empty | Empty | Empty | Empty | Empty | Empty | Empty | Empty | Empty | Empty | Empty | Empty |
| h | Empty | Empty | Empty | Empty | Empty | Empty | Empty | Empty | Empty | Empty | Empty | Empty |
